Skip to main content
. 2013 Feb 1;14(2):81–89. doi: 10.4161/cbt.22958

Table 1. Summary table of selective potential drugs/compounds targeting cancer metabolism pathways and mode of action.

Drug/compound Molecular target Mode of action
Phloretin
GLUT1
Blocks glucose uptake
Fasentin
GLUT1
Blocks glucose uptake
2-Deoxyglucose
Hexokinase
Blocks glycolytic flux
3-Bromopyruvate
Hexokinase
Blocks glycolytic flux
Clotrimazole
Hexokinase
Blocks glycolytic flux
Iodoacetate
G3PDH
Blocks glycolytic flux
Fluoride
enolase
Blocks glycolytic flux
FX11
Lactate dehydrogenase
Blocks metabolic flux
Dichloroacetate
Pyruvate dehydrogenase kinase
Promotes oxidative phosphorylation
PKM2 inhibitor
Pyruvate kinase 2
Prevents ATP production in hypoxia cancer cells
PKM2 activator
Pyruvate kinase 2
Promotes oxidative cellular damage in oxygenated cancer cells
Buthionine S′R′-sulfoximine
G6PD
Inhibits oxidative PPP pathway
6-aminonicotinamide
G6PD
Inhibits oxidative PPP pathway
Chloroquine
autophagy
Cuts off stromal fuel supply
Metformin
Energy sensing pathways(AMPK)
Inhibits lipolysis and oxidative phosphorylation
C93
FASN
Inhibits fatty acid synthesis
FAS31
FASN
Inhibits fatty acid synthesis
Rotenone
Mitochondrial respiration complex I
Inhibits oxidative phosphorylation
α-TOS
Mitochondrial respiration complex II
Genarates reactive oxygen species
Benzylisothiocyanate
Mitochondrial respiration complex Ш
Genarates reactive oxygen species
Oligomycin
Mitochondrial respiration complex IV
Inhibits ATP synthesis
Resveratrol
Mitochondrial respiration complex IV
Inhibits ATP synthesis
L-asparaginase
Glutamine uptake
Depletes blood glutamine level
L-γ-glutamyl-p-nitroanilide (GPNA)
SLC1A5 (a target of Myc)
Inhibits glutamine uptake and inhibits mTOR activation
968
Glutaminase
Inhibits Rho GTPases
Aminoxyacetic acid (AOA) Glutamine aminotransferase Inhibits transamination